drugset / Trial / NCT00506129

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

NCT00506129

Phase 2 Completed 33 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to see if receiving a transplant of blood stem cells (cells that can produce blood) or bone marrow from either a related donor (brother, sister or other relative) or an unrelated voluntary donor will help patients with advanced cutaneous T-cell lymphoma. The length of time that patients who receive the treatment remain free of disease will also be studied.

Timeline

Start
2003-09
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Background Fludarabine Small molecule 25 mg/m2 Intravenous
Background Melphalan Small molecule 70 mg/m2 Intravenous
Background Thymoglobulin Protein / enzyme biologic 2 mg/kg Intravenous